These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21194399)

  • 1. Platelet high-density lipoprotein activates transferrin-derived phagocytosis activators, MAPPs, following thrombin digestion.
    Sakamoto H; Wu B; Nagai Y; Tanaka S; Onodera M; Ogawa T; Ueno M
    Platelets; 2011; 22(5):371-9. PubMed ID: 21194399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein Ibalpha-bound thrombin functions as a serine protease to produce macromolecular activators of phagocytosis from platelets.
    Sakamoto H; Ueno M; Yanghong W; Khatun R; Tanaka S; Miyabe K; Ogawa Y; Onodera M
    Biochem Biophys Res Commun; 2000 Apr; 270(2):377-82. PubMed ID: 10753633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel function of transferrin as a constituent of macromolecular activators of phagocytosis from platelets and their precursors.
    Sakamoto H; Sakamoto N; Oryu M; Kobayashi T; Ogawa Y; Ueno M; Shinnou M
    Biochem Biophys Res Commun; 1997 Jan; 230(2):270-4. PubMed ID: 9016764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of macromolecular activators of phagocytosis by lysed platelets.
    Ogawa Y; Sakamoto H; Oryu M; Shinnou M; Sakamoto N; Yanghong W; Khatun R; Nishioka M
    Thromb Res; 2000 Mar; 97(5):297-306. PubMed ID: 10709905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of macromolecular phagocytosis activators released from platelets.
    Sakamoto H; Yokoya Y
    J Leukoc Biol; 1991 Oct; 50(4):356-63. PubMed ID: 1919363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of platelet release products on neutrophilic Fc gamma receptors.
    Sakamoto N; Sakamoto H; Tanaka S; Oryu M; Ogawa Y
    J Leukoc Biol; 1998 Nov; 64(5):631-5. PubMed ID: 9823768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro control of neutrophilic phagocytosis of IgG-coated SRBC by macromolecules involved in released products from platelets.
    Sakamoto H; Yokoya Y; Ooshima A
    J Leukoc Biol; 1987 Jan; 41(1):55-62. PubMed ID: 3468187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of human platelets using a rabbit antibody against H18-K24 of apolipoprotein CIII (HATKTAK).
    Yamanaka T; Sakamoto H; Nakagawa T; Tanaka S; Matsumoto K; Ueno M
    Pathol Int; 2013 Aug; 63(8):398-407. PubMed ID: 23957915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of macromolecular activators of phagocytosis from platelets (MAPP) producing and releasing function in stored human platelets.
    Sakamoto H; Ogawa Y; Sakamoto N; Oryu M; Shinnou M; Hirao T
    Int J Hematol; 1996 Feb; 63(2):143-8. PubMed ID: 8867724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on macromolecular activators of phagocytosis from platelets (MAPPs) using anti MAPP murine monoclonal antibodies.
    Yokoya Y; Sakamoto H; Oryu M; Uda H
    Br J Haematol; 1992 Jun; 81(2):241-6. PubMed ID: 1643021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-modified lipoprotein induced by thrombin: effect of whole blood and plasma.
    Aviram M; Maor I; Rosenblat M; Dankner G; Brook JG
    Isr J Med Sci; 1988; 24(4-5):193-200. PubMed ID: 3378876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified HDL-apolipoproteins, A-I and C-III, substitute for HDL in promoting the growth of SV40-transformed REF52 cells in serum-free medium.
    Chen JK; LaBrake-Farmer S; McClure DB
    J Cell Physiol; 1986 Sep; 128(3):413-20. PubMed ID: 3018002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platelet release products on neutrophilic activity in human whole blood.
    Wu B; Liu G; Yube K; Ueno M; Tanaka S; Onodera M; Jin Z; Sakamoto H
    Inflamm Res; 2009 Jun; 58(6):321-8. PubMed ID: 19234810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet modulation of neutrophil superoxide anion production.
    Moon DG; van der Zee H; Weston LK; Gudewicz PW; Fenton JW; Kaplan JE
    Thromb Haemost; 1990 Feb; 63(1):91-6. PubMed ID: 2160133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
    Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape of phagocytosis-activating function from platelets into plasma during storage.
    Yokoya Y; Sakamoto H
    Vox Sang; 1992; 62(1):34-8. PubMed ID: 1580065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions.
    Biró E; Akkerman JW; Hoek FJ; Gorter G; Pronk LM; Sturk A; Nieuwland R
    J Thromb Haemost; 2005 Dec; 3(12):2754-63. PubMed ID: 16359513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation.
    Desai K; Bruckdorfer KR; Hutton RA; Owen JS
    J Lipid Res; 1989 Jun; 30(6):831-40. PubMed ID: 2794776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.